ROBERT A. BAIOCCHI, M.D.
Osteopathic Medicine in Columbus, OH
License number
Ohio 35.080474
Category
Osteopathic Medicine
Type
Medical Oncology
License number
Ohio 35080474
Category
Osteopathic Medicine
Type
Hematology
Address
Address
320 Starling Loving Hall, Columbus, OH 43210
Phone
(614) 293-8508
(614) 293-4812 (Fax)
(614) 947-3700
(614) 293-4812 (Fax)
(614) 947-3700
Personal information
See more information about ROBERT A. BAIOCCHI at radaris.comName
Address
Phone
5283 Saddlebrook Dr, Columbus, OH 43221
5283 Saddlebrook Ct, Columbus, OH 43221
9401 Cape Wrath Dr, Dublin, OH 43017
5283 Saddlebrook Dr, Hilliard, OH 43026
5283 Saddlebrook Dr, Columbus, OH 43221
Organization information
See more information about ROBERT A. BAIOCCHI at bizstanding.comRobert Baiocchi MD,PHD
300 W 10 Ave, Columbus, OH 43210
Industry:
Internist
Site:
Phone:
(614) 293-8619 (Phone)
Description:
There are 56 doctors at this site. Surgery is not performed at this site.
Robert Alan Baiocchi
Professional information
See more information about ROBERT A. BAIOCCHI at trustoria.com
Dr. Robert A Baiocchi, Columbus OH - MD (Doctor of Medicine)
Dr. Robert A Baiocchi, Columbus OH - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
Starling-Loving Hall
320 W 10Th Ave, Columbus 43210
(614) 366-4961 (Phone), (614) 366-0003 (Fax)
OSU Comprehensive Cancer Center
300 W 10Th Ave, Columbus 43210
(614) 293-3241 (Phone), (614) 293-4044 (Fax)
OSU Comprehensive Cancer Ctr
300 W 10Th Ave, Columbus 43210
(614) 293-8619 (Phone)
320 W 10Th Ave, Columbus 43210
(614) 366-4961 (Phone), (614) 366-0003 (Fax)
OSU Comprehensive Cancer Center
300 W 10Th Ave, Columbus 43210
(614) 293-3241 (Phone), (614) 293-4044 (Fax)
OSU Comprehensive Cancer Ctr
300 W 10Th Ave, Columbus 43210
(614) 293-8619 (Phone)
Certifications:
Internal Medicine, 2003, Medical Oncology, 2008
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Starling-Loving Hall
320 W 10Th Ave, Columbus 43210
OSU Comprehensive Cancer Center
300 W 10Th Ave, Columbus 43210
OSU Comprehensive Cancer Ctr
300 W 10Th Ave, Columbus 43210
James Cancer Hospital and Solove Research Institute
300 West 10Th Ave, Columbus 43210
Wexner Medical Center at The Ohio State University
410 West 10Th Ave, Columbus 43210
320 W 10Th Ave, Columbus 43210
OSU Comprehensive Cancer Center
300 W 10Th Ave, Columbus 43210
OSU Comprehensive Cancer Ctr
300 W 10Th Ave, Columbus 43210
James Cancer Hospital and Solove Research Institute
300 West 10Th Ave, Columbus 43210
Wexner Medical Center at The Ohio State University
410 West 10Th Ave, Columbus 43210
Education:
Medical School
Ohio State University College Of Medicine and Public Health
Graduated: 1999
Oh State University Hospital
Ohio State University College Of Medicine and Public Health
Graduated: 1999
Oh State University Hospital
Robert A Baiocchi, Columbus OH
Robert A Baiocchi, Columbus OH
Specialties:
Internist
Address:
320 W 10Th Ave, Columbus, OH 43210
Education:
Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
Method For Inducing Apoptosis Of Primary Central Nervous System B Cell Lymphomas
Method For Inducing Apoptosis Of Primary Central Nervous System B Cell Lymphomas
US Patent:
6042826, Mar 28, 2000
Filed:
Nov 14, 1997
Appl. No.:
8/969881
Inventors:
Michael A. Caligiuri - Columbus OH
Robert B. Baiocchi - Columbus OH
Robert B. Baiocchi - Columbus OH
Assignee:
Health Research, Inc. - Buffalo NY
International Classification:
A61K 39395, A61K 3816, C12P 2108, C07K 1600
US Classification:
4241301
Abstract:
A method for treating a primary central nervous system lymphoma in an individual relates to administering intrathecally or intralesionally a therapeutically effective amount of a Fas-cross-linking composition thereby inducing the lymphoma cells to undergo Fas-mediated cytotoxicity. The Fas-cross-linking composition may be an agonist anti-human Fas monoclonal antibody or fragments thereof, soluble Fas-ligand (Fas-L), and a combination thereof. In another embodiment, the lymphoma is pretreated with a composition that enhances Fas-mediated cytotoxicity induced by a Fas-cross-linking composition, followed by treatment with the Fas-cross-linking composition.
Methods To Treat Or Prevent Viral-Associated Lymphoproliferative Disorders
Methods To Treat Or Prevent Viral-Associated Lymphoproliferative Disorders
US Patent:
2009000, Jan 1, 2009
Filed:
Oct 12, 2005
Appl. No.:
11/577111
Inventors:
Robert A. Baiocchi - Columbus OH, US
Michael A. Caligiuri - Columbus OH, US
Anne M. Van Buskirk - Westerville OH, US
Michael A. Caligiuri - Columbus OH, US
Anne M. Van Buskirk - Westerville OH, US
Assignee:
THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION - Columbus OH
International Classification:
A61K 39/395, C12Q 1/68, C12Q 1/02
US Classification:
4241331, 4241581, 4241721, 435 6, 435 29
Abstract:
The disclosure relates to methods to prevent, treat, or slow the progression viral-associated lymphoproliferative disorders, EBV-associated lymphoproliferative disorders, and post-transplant lymphoproliferative disorders. In the methods, a TGF-β antagonist, e.g., an anti-TGF-β antibody is administered to a subject. Methods for treating viral-associated lymphoproliferative disorders and for enhancing T-cell responsiveness to a viral-associated lymphoproliferative disorder by administering a TGF-β antagonist are also described.